News & AnalysisNational Institutes of Health

Drug-Screening Program Looking for a Home

See allHide authors and affiliations

Science  21 Oct 2011:
Vol. 334, Issue 6054, pp. 299
DOI: 10.1126/science.334.6054.299

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Summary

A $70-million-a-year program launched 7 years ago at the U.S. National Institutes of Health (NIH) to help academic researchers move into industry-style drug discovery may soon be forced to scale back sharply. NIH Director Francis Collins has been one of its biggest champions. But the NIH Molecular Libraries, according to plan, must be weaned starting next year from the NIH director's office Common Fund and find support at other NIH institutes. In a time of tight budgets, nobody wants it.